Health-related quality of life and psychological status of women with primary Sjögren's syndrome

Zhaoxiang Liu, Zhenhua Dong, Xiaochun Liang, Jinhe Liu, Lei Xuan, Jing Wang, Gaili Zhang, Weixin HaoMedicine 2017 · DOI

TL;DR

This study reveals that women with primary Sjögren's syndrome (pSS) experience significantly lower quality of life and higher rates of anxiety and depression compared to the general population. Pain and fatigue are identified as the primary drivers of these issues, underscoring the need for targeted interventions to manage these symptoms and improve patient well-being.

What Problem Does This Paper Address?

Primary Sjögren's syndrome (pSS) is a chronic autoimmune disease characterized by widespread dryness (xerostomia, xerophthalmia) and often accompanied by systemic symptoms like joint pain, muscle aches, and fatigue. These debilitating symptoms, along with potential side effects from treatments, can severely impact a patient's daily life, leading to reduced quality of life and emotional distress. While the physical manifestations of pSS are well-documented, there's a need for a comprehensive understanding of how these symptoms translate into psychological burdens and overall life quality, particularly in large patient cohorts. This paper aims to quantify the extent of this impact and identify the specific factors contributing to the diminished quality of life and increased psychological distress in women with pSS.

Methods

The researchers conducted a cross-sectional study involving 304 women diagnosed with primary Sjögren's syndrome. To assess their health-related quality of life, they utilized the internationally recognized Short Form (36) Health Survey (SF-36), which measures eight key dimensions of health and yields scores for physical and mental component summaries (PCS and MCS). Psychological status was evaluated using the Hospital Anxiety and Depression Scale (HADS), which assesses anxiety and depression levels separately. Symptom severity, including pain, fatigue, and dryness, was self-reported using a Visual Analogue Scale (VAS). Statistical analysis involved multivariate linear regression models to identify predictors of quality of life and psychological status, with significance set at P<.05.

Datasets

The study utilized data from 304 women diagnosed with primary Sjögren's syndrome at Peking Union Medical College Hospital between 2011 and 2014. For comparative purposes, the researchers referenced data from a general population SF-36 survey of 17,754 individuals across six Chinese provinces and HADS data from 6,581 patients treated in an Internal Medicine Department. No new datasets were introduced.

Key Insights and Ideas

  • The pervasive impact of pSS: The study strongly confirms that pSS significantly diminishes the quality of life for affected women, affecting both their physical and mental well-being. This isn't just about dryness; it's a systemic issue with broad implications.
  • Pain and fatigue are the primary culprits: The research highlights that pain and fatigue are not just symptoms but are the main drivers of reduced quality of life and are strongly linked to increased anxiety and depression. This suggests that effectively managing these two symptoms could be a cornerstone of improving patient outcomes.
  • Anxiety and depression are common comorbidities: The high scores on the HADS indicate that anxiety and depression are not minor concerns but significant psychological burdens for women with pSS, often exceeding those seen in patients with other internal diseases.
  • Age and specific symptoms matter for psychological distress: While pain and fatigue contribute to both anxiety and depression, younger age was specifically linked to higher anxiety, and xeroderma (dry skin) emerged as a factor contributing to depression.

Key Results

  • Lower Quality of Life: pSS patients exhibited significantly lower SF-36 scores across all dimensions compared to the general population (P<.001). The mean PCS score was 55.72±19.78, and the mean MCS score was 50.81±22.91.
  • Elevated Anxiety and Depression: pSS patients reported significantly higher HAS (median 7) and HDS (median 6) scores compared to patients with other internal diseases (HAS: 3.37±2.81, HDS: 3.83±3.14; both P<.001).
  • Predictors of Lower Quality of Life: Pain (β=-0.225, P<.001) and fatigue (β=-0.298, P<.001) negatively impacted PCS. Fatigue (β=-0.319, P<.001) negatively impacted MCS.
  • Factors Influencing Anxiety and Depression:
    • Anxiety: Younger age (β=-0.059, P=.035), pain (β=0.025, P=.028), and fatigue (β=0.029, P=.004) were associated with increased anxiety.
  • Depression: Xeroderma (β=0.030, P=.003), pain (β=0.022, P=.047), and fatigue (β=0.033, P=.001) were associated with increased depression.
  • Correlation: Lower quality of life (PCS/MCS) was negatively correlated with both anxiety and depression scores (P<.001).

Limitations and Future Work

The authors acknowledge the inherent limitations of a cross-sectional study, which cannot establish causality. They suggest that prospective, multi-centered studies are needed to validate these findings. Additionally, the study focused solely on female pSS patients due to the low number of males in their cohort, limiting generalizability to the entire pSS population. Future work should aim to address these limitations by including male patients and employing longitudinal designs to better understand the causal relationships between symptoms, psychological status, and quality of life in pSS. The findings also strongly advocate for enhanced clinical focus on pain and fatigue management, as well as psychological support, for pSS patients.

Summary updated

Abstract

Patients with primary Sjögren syndrome (pSS) always suffer from dryness, pain, and fatigue caused by the involvement of multiple different systems or organs. The uncomfortable disease symptoms, the consequent disability, and the side effects of therapeutic drugs decrease the quality of life and lead to emotional problems. We investigated the health-related quality of life and psychological status of a large cohort of women patients with pSS and associated factors.A total of 304 women with pSS referred to Peking Union Medical College Hospital during 2011 and 2014 were included. The internationally recognized Short Form (36) Health Survey (SF-36) was used to assess patients' quality of life; a higher score indicated a better quality of life. Patients' psychological status was assessed by the Hospital Anxiety and Depression Scale (HADS), and higher scores predicted more anxiety or depression.Patients with pSS had remarkably lower SF-36 scores. The Hospital Anxiety Scale (HAS) and Hospital Depression Scale (HDS) scores of the pSS patients (7 [4,10] and 6 [3,10], respectively) were significantly higher than that of patients with other internal diseases (3.37 ± 2.81 and 3.83 ± 3.14; both P < .001). Negative predictors of quality of life were: pain (physical condition, β = -0.225; P < .001); fatigue (physical condition, β = -0.298; P < .001; and mental condition, β = -0.319; P < .001). Risk factors for anxiety were: young age (β = -0.059; P = .035); pain (β = 0.025; P = .028); or fatigue (β = 0.029; P = .004). Risk factors for depression were: xeroderma (β = 0.030; P = .003); pain (β = 0.022; P = .047); or fatigue (β = 0.033; P = .001).Patients with pSS have a low quality of life with anxiety and depression. Pain and fatigue are primary factors for lower quality of life, which cause more anxiety and depression.
BibTeX
@inproceedings{liu2017health,
  author = {Zhaoxiang Liu and Zhenhua Dong and Xiaochun Liang and Jinhe Liu and Lei Xuan and Jing Wang and Gaili Zhang and Weixin Hao},
  title = {{Health-related quality of life and psychological status of women with primary Sjögren's syndrome}},
  booktitle = {Medicine},
  year = {2017},
  doi = {10.1097/md.0000000000009208},
}
Figure